{"id":"NCT00902746","sponsor":"Nobelpharma","briefTitle":"Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis","officialTitle":"Phase3, Open-Label, Long-Term, NSAID-Add-on, Clinical Trial of NPC-01 for Treatment of Dysmenorrhea Associated With Endometriosis.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05","primaryCompletion":"2012-02","completion":"2012-02","firstPosted":"2009-05-15","resultsPosted":"2014-06-13","lastUpdate":"2025-06-15"},"enrollment":149,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Dysmenorrhea"],"interventions":[{"type":"DRUG","name":"NPC-01","otherNames":[]}],"arms":[{"label":"NPC-01","type":"EXPERIMENTAL"}],"summary":"The purpose of this long-term study is to determine whether NPC-01 is effective in the treatment of dysmenorrhea associated with endometriosis.","primaryOutcome":{"measure":"Patient Response to Treatment for Dysmenorrhea, as Evaluated by Difference of Total Dysmenorrhea Score (Baseline/Pretreatment-End of Treatment)","timeFrame":"52 weeks","effectByArm":[{"arm":"NPC-01","deltaMin":2.4,"sd":1.8}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":147},"commonTop":["Metrorrhagia","Nasopharyngitis","Oligomenorrhoea","Headache","Nausea"]}}